Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Prometheus Obtains Exclusive US Commercialization Rights for RENCAREX® - PR Newswire (press release) |
 |
 |
|
PR Newswire (press release) RENCAREX® is a Phase III product candidate for adjuvant use in non-metastatic clear-cell renal cell cancer (ccRCC). Under the terms of the agreement, WILEX will receive $19.0 million upfront payments and development fees plus milestone payments and |
